34
Participants
Start Date
July 16, 2025
Primary Completion Date
August 1, 2026
Study Completion Date
September 1, 2026
Genicular nerve block with bupivacaine and corticosteroids
genicular nerve block with ideal body-weight dosing of bupivacaine 0.5% with 4 mg dexamethasone
Standard of Care
This involves standard of care pain relief for patients who do not receive the genicular nerve block for knee pain, such as acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), and opioids.
RECRUITING
Hospital of the University of Pennsylvania, Philadelphia
RECRUITING
Pennsylvania Hospital, Philadelphia
RECRUITING
Pennsylvania Presbyterian Medical Center, Philadelphia
RECRUITING
HUP Cedar, Philadelphia
University of Pennsylvania
OTHER